Literature DB >> 7350460

Platelet activation during exercise-induced myocardial ischemia.

L H Green, E Seroppian, R I Handin.   

Abstract

Because platelet activation may be important in the worsening of coronary atherosclerosis, we used a radioimmunoassay for platelet factor 4 to study platelet behavior in patients with coronary-artery disease. Forty patients had paired blood samples withdrawn for measurement of the plasma level of platelet factor 4 before and after a standardized exercise-tolerance test. Twenty patients had positive tests, and 19 of those 20 had clinical or angiographic evidence of coronary-artery disease. Eleven of the 20 had a greater than 50 per cent increase in platelet factor 4 after exercise. The remaining nine had positive exercise tests without rises in platelet factor 4. Elevated levels returned to normal within 15 minutes of exercise. Eighteen of 20 patients with negative exercise tests had no rise in platelet factor 4 after exercise. We conclude that a subset of patients with coronary-artery disease and exercise-induced myocardial ischemia had evidence of platelet activation and secretion. (N Engl J Med 302:193-197, 1980).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350460     DOI: 10.1056/NEJM198001243020403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  12 in total

1.  The effect of exercise on bleeding time and local production of prostacyclin and thromboxane.

Authors:  J W Carter; A E Ready; S Singhroy; E Duta; J M Gerrard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

2.  Acute haemodynamic and platelet effects of felodipine in hypertensive patients.

Authors:  H M McAlpine; I D Walker; J F Davidson; T D Lawrie; A R Lorimer
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 3.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

Review 4.  Platelet markers of thromboembolic disease.

Authors:  H Wohl
Journal:  West J Med       Date:  1981-07

5.  The effect of prolonged treatment with sulphinpyrazone on thromboxane A2 and prostacyclin in man.

Authors:  L Viinikka; J Toivanen; O Ylikorkala
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

6.  The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases.

Authors:  J De Cree; J Leempoels; B Demoen; V Roels; H Verhaegen
Journal:  Agents Actions       Date:  1985-07

7.  Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.

Authors:  J F Eidt; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

8.  Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease.

Authors:  E Minar; H Ehringer; R Schöfl
Journal:  Klin Wochenschr       Date:  1987-05-04

9.  Circadian variations in pathogenesis of ST-segment elevation myocardial infarction: an optical coherence tomography study.

Authors:  Makoto Araki; Taishi Yonetsu; Osamu Kurihara; Akihiro Nakajima; Hang Lee; Tsunenari Soeda; Yoshiyasu Minami; Takumi Higuma; Shigeki Kimura; Masamichi Takano; Bryan P Yan; Tom Adriaenssens; Niklas F Boeder; Holger M Nef; Chong Jin Kim; Filippo Crea; Tsunekazu Kakuta; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

10.  Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.

Authors:  H J Jürgensen; J Dalsgaard-Nielsen; E Kjøller; J Gormsen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.